These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
47. Correlations between morphological and functional microcirculatory alterations in diabetes and the impact of metabolic control and disease duration. Meyer MF; Pfohl M; Schatz H Microvasc Res; 2000 Jan; 59(1):186-9. PubMed ID: 10625588 [No Abstract] [Full Text] [Related]
48. Capillary blood flow abnormalities in the skeletal muscle and microvascular complications in diabetes lessons that cannot be learned from larger vessels. Porter TR J Am Coll Cardiol; 2009 Jun; 53(23):2184-5. PubMed ID: 19497446 [No Abstract] [Full Text] [Related]
49. Plasma thrombomodulin: a marker for microvascular complications in diabetes mellitus. Gabat S; Keller C; Kempe HP; Amiral J; Ziegler R; Ritz E; Bergis KH; Wahl P; Nawroth P Vasa; 1996; 25(3):233-41. PubMed ID: 8795304 [TBL] [Abstract][Full Text] [Related]
50. Molecular mechanisms linking diabetes to the accelerated development of atherosclerosis. Zeadin MG; Petlura CI; Werstuck GH Can J Diabetes; 2013 Oct; 37(5):345-50. PubMed ID: 24500563 [TBL] [Abstract][Full Text] [Related]
51. The aetiology of diabetic neuropathy: the combined roles of metabolic and vascular defects. Stevens MJ; Feldman EL; Greene DA Diabet Med; 1995 Jul; 12(7):566-79. PubMed ID: 7554777 [TBL] [Abstract][Full Text] [Related]
52. Neutrophil-lymphocyte ratio correlates with limited joint mobility of hand in patients with type 2 diabetes. Mineoka Y; Ishii M; Hashimoto Y; Nakamura N; Katsumi Y; Isono M; Fukui M Endocr J; 2018 Oct; 65(10):1011-1017. PubMed ID: 30012904 [TBL] [Abstract][Full Text] [Related]
53. The neurology of diabetes mellitus in Central Africa. Rolfe M Diabet Med; 1988; 5(4):399-401. PubMed ID: 2968895 [TBL] [Abstract][Full Text] [Related]
54. Postischemic microcirculatory blood flow correlates negatively and independently with plasma C-reactive protein in longstanding type 1 diabetes. Gibney J; Weis U; Turner B; Meeking DR; Cansfield J; Watts GF; Shaw KM; Cummings MH Diabetes Care; 2002 Apr; 25(4):802-3. PubMed ID: 11919146 [No Abstract] [Full Text] [Related]
55. Effect of cilostazol on experimental diabetic neuropathy in the rat. Kihara M; Schmelzer JD; Low PA Diabetologia; 1995 Aug; 38(8):914-8. PubMed ID: 7589876 [TBL] [Abstract][Full Text] [Related]
56. Rheological changes in diabetic microangiopathy. Negrean V; Suciu I; Sâmpelean D; Cozma A Rom J Intern Med; 2004; 42(2):407-13. PubMed ID: 15529630 [TBL] [Abstract][Full Text] [Related]
57. Impaired peripheral vasomotion in diabetes. Stansberry KB; Shapiro SA; Hill MA; McNitt PM; Meyer MD; Vinik AI Diabetes Care; 1996 Jul; 19(7):715-21. PubMed ID: 8799625 [TBL] [Abstract][Full Text] [Related]
58. Granulocyte colony-stimulating factor provides protection against cardiovascular autonomic neuropathy in streptozotocin-induced diabetes in rats. Erbaş O; Solmaz V; Taşkıran D Diabetes Res Clin Pract; 2015 Mar; 107(3):377-83. PubMed ID: 25638453 [TBL] [Abstract][Full Text] [Related]
59. Peripheral vascular disease and type 2 diabetes mellitus. Schaper NC; Nabuurs-Franssen MH; Huijberts MS Diabetes Metab Res Rev; 2000; 16 Suppl 1():S11-5. PubMed ID: 11054881 [TBL] [Abstract][Full Text] [Related]